欢迎来到天天文库
浏览记录
ID:56058750
大小:384.61 KB
页数:4页
时间:2020-06-20
《氨氯地平治疗糖尿病合并高血压并发肾脏损害效果的系统评价.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、论著ONTHE氨氯地平治疗糖尿病合并高血压并发肾脏损害效果的系统评价胡乾配谢波李一梅江莲罗天勇韩琳娜李琼(重庆医科大学附属永川医院全科医学科402160)【摘要1目的采用系统评价方法,研究氨氯地平与缬沙坦相比治疗糖尿病合并高血压并发’肾脏损害的效果。方法计算机检索万方、CNKI、VIP、CBM、CochraneLibrary、PubMed、EMbase、OVID等数据库CochraneLibrary检索至2013年第10n,余数据库检索时限为建库至2013年1O月,手工检索会议文献及杂志。按照Cochrane系统评价方法,由2名研究人员独立评价文献,核对纳入
2、研究的质量评价及提取的有效数据,用RevMan5.2软件进行Meta分析。结果最终纳入9篇随机对照试验文献,其中中文7篇,英文2篇。Meta分析结果显示,氨氯地平改善UAER、24h尿蛋白的效果优于缬沙坦:UAER:WMD=一16.65,95%CI(一18.05,一15.25),P<0.00001;24h尿蛋白:AbR:WMD=-10.24,95%CI(一18.52,一1.95),P=0.02;B组:WMD~575.69,95%cI(一781.02,一370.36),P3、D=I.05,95%CI(一3.89,5.99),P=0.68;SBP:WldD=0.21,95%CI(-0.91,1.33),P=0.71;DBP:WMD=-0.11,95%CI(-0.90,0.68),P=0.78;不艮反应发生率:WMD=I.O0,95%CI(O.3,3.34),P=I.O0。结论与缬沙坦相比,氨氯地平对治疗糖尿病合并高血压并发的肾脏损害同样有效,在临床上可作为一线药物选用。【关键词】:氨氯地平缬沙坦糖尿病高血压肾脏损害系统评价Efficacyofamlodipineonrenaiinvolvementcomplicatedbydiab4、etesmel1ituswithhypertension:asystematicreviewHUQian-pei,XIEBo,LIYi-mei,JIANGLian,LUOTian-yong,HANLin-na,LIQiongDepartmentofGeneralPractice,YongchuanHospita1AffiiiatedtoChongqingMedica1University[Abstract]ObjectiveTosystematicallyreviewtheefficacyofamlodipinecomparedwithvalsartanin5、treatmentofrenalinvolvementcomp1icatedbydiabetesme11ituswithhypertension.MethodsAI1relevant1iteratureswereretrievedfromdatabaseofWanfang,CNKI,VIP,CBM,CochraneLibrary,PubMed,EMbaseandOVIDuptoNovember2013.Papersofrelatedconferenceandmagazinewerea1sosearchedmanua11Y.Withtheevaluationm6、ethodrecommendedbyCochraneCollaboration.tworeviewersassessedthequa1itvofthesearched1iteraturesandextracteddatafromtheincludedstudies.Meta-analysiswasconductedusingRevMan5.2.ResultsNinerandomizedcontrolledtria1swerefina11Yinclud'ed.Ofthem,sevenwereChineseandtheremainingtwowereEng1is7、h.Themeta-analysisshowedthatamlodipineimprovingurinealbuminexcretionrate(UAER)wasbetterthanva1sartan[WMD--16.65,95%CI(-18.05,一15.25),P<0.00001】.However,therewasnosignificantdifferenceinlowingsysto1icbloodpressure(SBP),diasto1icbloodpressure(DBP),24-hourproteinuria,Serumcreatinine(S8、cr)andincidenceofadverseev
3、D=I.05,95%CI(一3.89,5.99),P=0.68;SBP:WldD=0.21,95%CI(-0.91,1.33),P=0.71;DBP:WMD=-0.11,95%CI(-0.90,0.68),P=0.78;不艮反应发生率:WMD=I.O0,95%CI(O.3,3.34),P=I.O0。结论与缬沙坦相比,氨氯地平对治疗糖尿病合并高血压并发的肾脏损害同样有效,在临床上可作为一线药物选用。【关键词】:氨氯地平缬沙坦糖尿病高血压肾脏损害系统评价Efficacyofamlodipineonrenaiinvolvementcomplicatedbydiab
4、etesmel1ituswithhypertension:asystematicreviewHUQian-pei,XIEBo,LIYi-mei,JIANGLian,LUOTian-yong,HANLin-na,LIQiongDepartmentofGeneralPractice,YongchuanHospita1AffiiiatedtoChongqingMedica1University[Abstract]ObjectiveTosystematicallyreviewtheefficacyofamlodipinecomparedwithvalsartanin
5、treatmentofrenalinvolvementcomp1icatedbydiabetesme11ituswithhypertension.MethodsAI1relevant1iteratureswereretrievedfromdatabaseofWanfang,CNKI,VIP,CBM,CochraneLibrary,PubMed,EMbaseandOVIDuptoNovember2013.Papersofrelatedconferenceandmagazinewerea1sosearchedmanua11Y.Withtheevaluationm
6、ethodrecommendedbyCochraneCollaboration.tworeviewersassessedthequa1itvofthesearched1iteraturesandextracteddatafromtheincludedstudies.Meta-analysiswasconductedusingRevMan5.2.ResultsNinerandomizedcontrolledtria1swerefina11Yinclud'ed.Ofthem,sevenwereChineseandtheremainingtwowereEng1is
7、h.Themeta-analysisshowedthatamlodipineimprovingurinealbuminexcretionrate(UAER)wasbetterthanva1sartan[WMD--16.65,95%CI(-18.05,一15.25),P<0.00001】.However,therewasnosignificantdifferenceinlowingsysto1icbloodpressure(SBP),diasto1icbloodpressure(DBP),24-hourproteinuria,Serumcreatinine(S
8、cr)andincidenceofadverseev
此文档下载收益归作者所有